<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Kidney Function &#187; Graeme C. Smith, Thomas Trauer, Peter G. Kerr, Steven J. Chadban</title>
	<atom:link href="http://kidneyfunction.org/author/graeme-c-smith-thomas-trauer-peter-g-kerr-steven-j/feed/" rel="self" type="application/rss+xml" />
	<link>http://kidneyfunction.org</link>
	<description>Renal Information</description>
	<lastBuildDate>Fri, 03 Sep 2010 23:00:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Prospective Quality-of-Life Monitoring of Simultaneous Pancreas and Kidney Transplant Recipients Using the 36-Item Short Form Health Survey &#8211; Corrected Proof</title>
		<link>http://kidneyfunction.org/prospective-quality-of-life-monitoring-of-simultaneous-pancreas-and-kidney-transplant-recipients-using-the-36-item-short-form-health-survey-corrected-proof/</link>
		<comments>http://kidneyfunction.org/prospective-quality-of-life-monitoring-of-simultaneous-pancreas-and-kidney-transplant-recipients-using-the-36-item-short-form-health-survey-corrected-proof/#comments</comments>
		<pubDate>Mon, 22 Feb 2010 03:00:00 +0000</pubDate>
		<dc:creator>Graeme C. Smith, Thomas Trauer, Peter G. Kerr, Steven J. Chadban</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">10.1053/j.ajkd.2009.12.025</guid>
		<description><![CDATA[Background: Few risk factors for quality-of-life outcomes of simultaneous pancreas and kidney transplant recipients are known because of a paucity of data from prospective studies.Study Design: Pretransplant assessment and prospective 3-year follow-up.Setting &#38; Participants: Consecutive potential recipients at a university teaching hospital assessed by Liaison Psychiatry.Predictors: Demographic data; pretransplant Transplant Evaluation Rating Scale scores; current, past 12 months, and prior lifetime psychiatric disorder.Outcomes &#38; Measurements: 36-Item Short Form Health Survey (SF-36) scores.Results: 37 simultaneous pancreas and kidney transplant recipients were assessed pretransplant and at 4 months posttransplant. Posttransplant at 1 year, 29 (81% of survivors); at 2 years, 26 (79% of survivors and those reaching 2 years); and at 3 years, 22 (92% of survivors and those reaching 3 years) patients were assessed. SF-36 Mental Component Summary (MCS) scores (mean pretransplant, 46.8 ± 8.2 [SD]; 4 months, 51.7 ± 8.5; 1 year, 50.1 ± 9.7; 2 years, 51.8 ± 8.9; and 3 years, 50.8 ± 13.8) and Physical Component Summary (PCS) scores (pretransplant, 40.6 ± 10.6; 4 months, 43.6 ± 12.0; 1 year, 45.6 ± 11.3; 2 years, 48.1 ± 10.2; and 3 years, 46.8 ± 9.1) showed sustained improvement posttransplant. MCS scores became similar to population norms. Functionally significant decreases in MCS and PCS scores were seen in 4%-21% and 8%-30% at times posttransplant. Male sex predicted higher scores at 4 months for the MCS (P = 0.003; regression coefficient, −8.28 [95% CI, −13.6 to −2.9]; effect size, 0.22) and PCS (P = 0.05; regression coefficient, −6.91 [95% CI, −13.9 to 0.9]; effect size, 0.08). Current psychiatric disorder at pretransplant evaluation predicted higher PCS scores at 4 months (P = 0.002; regression coefficient, −15.42 [95% CI, −24.6 to −6.2]; effect size, 0.22) and 1 year (P = 0.002; regression coefficient, −17.3 [95% CI, −27.9 to −6.7]; effect size, 0.29). Psychiatric disorder before the 12 months before the pretransplant evaluation predicted lower PCS scores at 4 months posttransplant (P &#60; 0.001; regression coefficient, 14.98 [95% CI, 7.1-22.8]; effect size, 0.29).Limitations: Cohort size.Conclusions: Although half experienced sustained quality-of-life improvement, up to one-third experienced a decrease. Past psychiatric disorder is a risk factor. Patients should be educated and monitored appropriately.]]></description>
			<content:encoded><![CDATA[Background: Few risk factors for quality-of-life outcomes of simultaneous pancreas and kidney transplant recipients are known because of a paucity of data from prospective studies.Study Design: Pretransplant assessment and prospective 3-year follow-up.Setting & Participants: Consecutive potential recipients at a university teaching hospital assessed by Liaison Psychiatry.Predictors: Demographic data; pretransplant Transplant Evaluation Rating Scale scores; current, past 12 months, and prior lifetime psychiatric disorder.Outcomes & Measurements: 36-Item Short Form Health Survey (SF-36) scores.Results: 37 simultaneous pancreas and kidney transplant recipients were assessed pretransplant and at 4 months posttransplant. Posttransplant at 1 year, 29 (81% of survivors); at 2 years, 26 (79% of survivors and those reaching 2 years); and at 3 years, 22 (92% of survivors and those reaching 3 years) patients were assessed. SF-36 Mental Component Summary (MCS) scores (mean pretransplant, 46.8 ± 8.2 [SD]; 4 months, 51.7 ± 8.5; 1 year, 50.1 ± 9.7; 2 years, 51.8 ± 8.9; and 3 years, 50.8 ± 13.8) and Physical Component Summary (PCS) scores (pretransplant, 40.6 ± 10.6; 4 months, 43.6 ± 12.0; 1 year, 45.6 ± 11.3; 2 years, 48.1 ± 10.2; and 3 years, 46.8 ± 9.1) showed sustained improvement posttransplant. MCS scores became similar to population norms. Functionally significant decreases in MCS and PCS scores were seen in 4%-21% and 8%-30% at times posttransplant. Male sex predicted higher scores at 4 months for the MCS (P = 0.003; regression coefficient, −8.28 [95% CI, −13.6 to −2.9]; effect size, 0.22) and PCS (P = 0.05; regression coefficient, −6.91 [95% CI, −13.9 to 0.9]; effect size, 0.08). Current psychiatric disorder at pretransplant evaluation predicted higher PCS scores at 4 months (P = 0.002; regression coefficient, −15.42 [95% CI, −24.6 to −6.2]; effect size, 0.22) and 1 year (P = 0.002; regression coefficient, −17.3 [95% CI, −27.9 to −6.7]; effect size, 0.29). Psychiatric disorder before the 12 months before the pretransplant evaluation predicted lower PCS scores at 4 months posttransplant (P < 0.001; regression coefficient, 14.98 [95% CI, 7.1-22.8]; effect size, 0.29).Limitations: Cohort size.Conclusions: Although half experienced sustained quality-of-life improvement, up to one-third experienced a decrease. Past psychiatric disorder is a risk factor. Patients should be educated and monitored appropriately.]]></content:encoded>
			<wfw:commentRss>http://kidneyfunction.org/prospective-quality-of-life-monitoring-of-simultaneous-pancreas-and-kidney-transplant-recipients-using-the-36-item-short-form-health-survey-corrected-proof/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
